NO830539L - Pyridinkarboksylsyreestere, fremgangsmaate til deres fremstilling samt deres anvendelse som legemiddel - Google Patents
Pyridinkarboksylsyreestere, fremgangsmaate til deres fremstilling samt deres anvendelse som legemiddelInfo
- Publication number
- NO830539L NO830539L NO830539A NO830539A NO830539L NO 830539 L NO830539 L NO 830539L NO 830539 A NO830539 A NO 830539A NO 830539 A NO830539 A NO 830539A NO 830539 L NO830539 L NO 830539L
- Authority
- NO
- Norway
- Prior art keywords
- acid esters
- medicine
- procedure
- preparation
- carboxylic acid
- Prior art date
Links
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical class OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 title abstract 2
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- 206010021143 Hypoxia Diseases 0.000 abstract 1
- 125000005041 acyloxyalkyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 230000007954 hypoxia Effects 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Treatment And Processing Of Natural Fur Or Leather (AREA)
- Drawers Of Furniture (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823209274 DE3209274A1 (de) | 1982-03-13 | 1982-03-13 | Pyridincarbonsaeureester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO830539L true NO830539L (no) | 1983-09-14 |
| NO162234B NO162234B (no) | 1989-08-21 |
| NO162234C NO162234C (no) | 1989-11-29 |
Family
ID=6158229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO830539A NO162234C (no) | 1982-03-13 | 1983-02-17 | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinkarboksylsyreestere. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4705794A (no) |
| EP (1) | EP0088940B1 (no) |
| JP (1) | JPS58167571A (no) |
| KR (1) | KR910000637B1 (no) |
| AT (1) | ATE19875T1 (no) |
| AU (1) | AU564367B2 (no) |
| CA (1) | CA1208216A (no) |
| DE (2) | DE3209274A1 (no) |
| DK (1) | DK157857C (no) |
| FI (1) | FI82687C (no) |
| GR (1) | GR78454B (no) |
| HU (1) | HU188851B (no) |
| IE (1) | IE54879B1 (no) |
| IL (1) | IL68095A (no) |
| NO (1) | NO162234C (no) |
| PH (1) | PH19685A (no) |
| PT (1) | PT76328B (no) |
| ZA (1) | ZA831691B (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58185821U (ja) * | 1982-06-02 | 1983-12-10 | 日産自動車株式会社 | ウインドシ−ルド |
| DE4342196A1 (de) * | 1993-12-10 | 1995-06-14 | Bayer Ag | Neue 4-Phenyl-substituierte 1,4-Dihydropyridine |
| DE3410645A1 (de) * | 1984-03-23 | 1985-09-26 | Bayer Ag, 5090 Leverkusen | L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| GB8530602D0 (en) * | 1985-12-12 | 1986-01-22 | Fujisawa Pharmaceutical Co | Heterocyclic compounds |
| IT1204948B (it) * | 1987-03-13 | 1989-03-10 | Boheringer Biochemia Robin S P | 2-tiometil-sostituite-piridine, metodo per la loro preparazione e composizioni farmaceutiche che le contengono. |
| DE3712371A1 (de) * | 1987-04-11 | 1988-10-27 | Bayer Ag | Substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung |
| DE3712369A1 (de) * | 1987-04-11 | 1988-10-27 | Bayer Ag | Substituierte 5-nitro-1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung |
| CA1312611C (en) * | 1987-07-01 | 1993-01-12 | Yamanouchi Pharmaceutical Co., Ltd. | Pyridine derivatives, process for production thereof and pharmaceutical composition containing them |
| US5100892A (en) * | 1990-11-13 | 1992-03-31 | Glaxo Inc. | Dihydropyridine vasodilator agents |
| EP0657432B1 (de) * | 1993-12-10 | 2003-03-12 | Bayer Ag | Phenyl-substituierte 1,4-Dihydropyridine mit cerebraler Aktivität |
| DE4430639A1 (de) | 1994-08-29 | 1996-03-07 | Bayer Ag | Verwendung von 5-substituierten Pyridin- und Hexahydrochinolin-3-carbonsäurederivaten |
| WO2005025507A2 (en) * | 2003-09-10 | 2005-03-24 | Synta Phamaceuticals Corp. | Dihydropyridine compounds for treating or preventing metabolic disorders |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1552911A (en) * | 1975-07-02 | 1979-09-19 | Fujisawa Pharmaceutical Co | 1,4 dihydropyridine derivatives and the preparation thereof |
| NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
| DE3209276A1 (de) * | 1982-03-13 | 1983-09-15 | Bayer Ag, 5090 Leverkusen | Arzneimittel mit antihypoxischer und ischaemie-protektiver wirkung |
-
1982
- 1982-03-13 DE DE19823209274 patent/DE3209274A1/de not_active Withdrawn
-
1983
- 1983-02-17 NO NO830539A patent/NO162234C/no unknown
- 1983-02-28 US US06/470,886 patent/US4705794A/en not_active Expired - Fee Related
- 1983-03-02 DE DE8383102001T patent/DE3363581D1/de not_active Expired
- 1983-03-02 EP EP83102001A patent/EP0088940B1/de not_active Expired
- 1983-03-02 AT AT83102001T patent/ATE19875T1/de active
- 1983-03-03 PT PT76328A patent/PT76328B/pt unknown
- 1983-03-07 AU AU12081/83A patent/AU564367B2/en not_active Ceased
- 1983-03-10 FI FI830810A patent/FI82687C/fi not_active IP Right Cessation
- 1983-03-10 IL IL68095A patent/IL68095A/xx unknown
- 1983-03-11 CA CA000423460A patent/CA1208216A/en not_active Expired
- 1983-03-11 GR GR70766A patent/GR78454B/el unknown
- 1983-03-11 HU HU83847A patent/HU188851B/hu not_active IP Right Cessation
- 1983-03-11 PH PH28638A patent/PH19685A/en unknown
- 1983-03-11 ZA ZA831691A patent/ZA831691B/xx unknown
- 1983-03-11 JP JP58039303A patent/JPS58167571A/ja active Granted
- 1983-03-11 KR KR1019830000979A patent/KR910000637B1/ko not_active IP Right Cessation
- 1983-03-11 IE IE535/83A patent/IE54879B1/en not_active IP Right Cessation
- 1983-03-11 DK DK117783A patent/DK157857C/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT76328A (en) | 1983-04-01 |
| FI82687B (fi) | 1990-12-31 |
| DK157857C (da) | 1990-07-30 |
| FI82687C (fi) | 1991-04-10 |
| HU188851B (en) | 1986-05-28 |
| PH19685A (en) | 1986-06-13 |
| DK157857B (da) | 1990-02-26 |
| FI830810A0 (fi) | 1983-03-10 |
| JPS58167571A (ja) | 1983-10-03 |
| KR910000637B1 (ko) | 1991-01-31 |
| DE3363581D1 (en) | 1986-06-26 |
| AU564367B2 (en) | 1987-08-13 |
| GR78454B (no) | 1984-09-27 |
| DK117783A (da) | 1983-09-14 |
| EP0088940A1 (de) | 1983-09-21 |
| NO162234B (no) | 1989-08-21 |
| PT76328B (en) | 1985-11-11 |
| DE3209274A1 (de) | 1983-09-15 |
| IE54879B1 (en) | 1990-03-14 |
| ZA831691B (en) | 1983-12-28 |
| AU1208183A (en) | 1983-09-15 |
| DK117783D0 (da) | 1983-03-11 |
| KR840004079A (ko) | 1984-10-06 |
| US4705794A (en) | 1987-11-10 |
| NO162234C (no) | 1989-11-29 |
| ATE19875T1 (de) | 1986-06-15 |
| CA1208216A (en) | 1986-07-22 |
| FI830810L (fi) | 1983-09-14 |
| EP0088940B1 (de) | 1986-05-21 |
| IE830535L (en) | 1983-09-13 |
| JPH0551581B2 (no) | 1993-08-03 |
| IL68095A (en) | 1986-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK114783A (da) | Hidtil ukendte forbindelser, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler | |
| DE3852565D1 (de) | Aryl-heteroaryl-karbinol-Derivate mit analgetischer Aktivität. | |
| NO830539L (no) | Pyridinkarboksylsyreestere, fremgangsmaate til deres fremstilling samt deres anvendelse som legemiddel | |
| DK436081A (da) | Substituerede acyl-derivater af 1,2,3,4-tetrahydroisoquinolin-3-carboxylsyrer og farmaceutisk acceptable salte deraf fremgangsmaade til deres fremstilling og deres anvendelse | |
| AU537414B2 (en) | Pyroglutamic acid derivatives | |
| DK164789C (da) | Analogifremgangsmaade til fremstilling af spirooe4.(3+n)aa-2-aza-3-carboxylsyrederivater eller physiologisk acceptable salte deraf samt udgangsforbindelser til anvendelse ved fremgangsmaaden | |
| NO883487L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser. | |
| NO862621D0 (no) | Fremgangsmaate ved fremstilling av pyridonkarboksylsyrederivater. | |
| DK76784A (da) | N-phenyl-benzamidderivater, fremgangsmaade til fremstilling heraf samt deres anvendelse til bekaempelse af sygdomme i immunsystemet | |
| DK118287A (da) | Heteroaryloxy-beta-carbolinderivater, deres fremstilling og deres anvendelse som laegemiddel | |
| DE3363248D1 (en) | Use of pyridine compounds for the manufacture of medicaments with an antihypoxemia and ischemia-protective activity | |
| SE7612308L (sv) | Sett att framstella 2,6-dimetyl-3-metoxikarbonyl-4-(2'-nitrofenyl)-1,4-dihydropyridin-5-karbonsyraisobutylester samt anvendning derav som kprpmarterapertikum. | |
| DK27081A (da) | Indan-4-yl-n-alkyl-carbaminsyreestere,fremgangsmaade til fremstilling heraf samt deres anvendelse som fungicider | |
| NO930844L (no) | 2-(2-substituerte pyrrolidinyltio)karbapenem-derivater | |
| AU576659B2 (en) | 5-sulphonamido-1-aryl-pyrazoles | |
| FI841293A0 (fi) | Iminosulfonamider och foerfarande foer deras framstaellning, dessa foereningar innehaollande farmaceutiska prepara preparat samt deras anvaendning. | |
| DK320582A (da) | Substituerede phenyl-cyclopropancarboxylsyreestere,fremgangsmaade til fremstilling deraf samt deres anvendelse som midler til bekaempelse af skadelige organismer |